1.26
price down icon1.56%   -0.02
after-market Handel nachbörslich: 1.27 0.01 +0.79%
loading

Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten

pulisher
Apr 05, 2026

Profit Review: Is Phio Pharmaceuticals Corp on track to beat earningsSwing Trade & Detailed Earnings Play Alerts - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 05, 2026

VIX Spike: Is Phio Pharmaceuticals Corp being accumulated by smart moneyQuarterly Risk Review & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 02, 2026

PHIO Stock Price, Quote & Chart | PHIO PHARMACEUTICALS CORP (NASDAQ:PHIO) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 - The National Law Review

Apr 01, 2026
pulisher
Mar 31, 2026

Phio Pharmaceuticals Secures cGMP Manufacturing for Clinical Supply - The Globe and Mail

Mar 31, 2026
pulisher
Mar 30, 2026

Phio Pharmaceuticals Signs U.S. cGMP Manufacturing Agreement for PH-762 Drug Product Clinical Supply - Minichart

Mar 30, 2026
pulisher
Mar 30, 2026

Phio Pharmaceuticals secures U.S. cGMP manufacturer for PH-762 clinical and commercial supply - TradingView

Mar 30, 2026
pulisher
Mar 30, 2026

Phio (NASDAQ: PHIO) inks PH-762 manufacturing deal after strong 65% response - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

Phio lines up U.S. supply for skin cancer drug as PH-762 trials advance - Stock Titan

Mar 30, 2026
pulisher
Mar 28, 2026

Dow Update: Can Phio Pharmaceuticals Corp lead its sector in growth - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 28, 2026

Phio Pharmaceuticals Corp (44R1.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Mar 28, 2026
pulisher
Mar 28, 2026

Phio Pharmaceuticals Corp (44R1.MU) stock price, news, quote and history - Yahoo Finance UK

Mar 28, 2026
pulisher
Mar 27, 2026

Financial Analysis: Galectin Therapeutics (NASDAQ:GALT) & Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Mar 27, 2026
pulisher
Mar 24, 2026

Phio Pharmaceuticals to present PH-762 cancer trial data Friday By Investing.com - Investing.com South Africa

Mar 24, 2026
pulisher
Mar 23, 2026

Phio Pharmaceuticals to present PH-762 cancer trial data Friday - Investing.com

Mar 23, 2026
pulisher
Mar 23, 2026

Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement - marketscreener.com

Mar 23, 2026
pulisher
Mar 23, 2026

A skin cancer study with 65% response sends Phio to a late-breaker stage - Stock Titan

Mar 23, 2026
pulisher
Mar 21, 2026

Cancer biotech Phio Pharmaceuticals stock surges as trial shows tumor clearance at highest dose in skin cancer patients - MSN

Mar 21, 2026
pulisher
Mar 17, 2026

Aug Macro: Is Phio Pharmaceuticals Corp a stock for growth or value investors2026 Historical Comparison & Step-by-Step Trade Execution Guides - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

Retail Trends: Is Phio Pharmaceuticals Corp being accumulated by smart money2026 Performance Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office - Bitget

Mar 16, 2026
pulisher
Mar 16, 2026

Phio cancer study sees ~65% response; CEO in March 18 virtual chat - Stock Titan

Mar 16, 2026
pulisher
Mar 13, 2026

Sidoti Boosts Earnings Estimates for Phio Pharmaceuticals - Defense World

Mar 13, 2026
pulisher
Mar 12, 2026

PHIO: RNA therapy for skin cancer shows 85% response and no toxicities, advancing to pivotal trials - TradingView

Mar 12, 2026
pulisher
Mar 11, 2026

Phio Pharmaceuticals Corp. Financial Disclosures & SEC Filings - TradingView

Mar 11, 2026
pulisher
Mar 10, 2026

Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT - GlobeNewswire

Mar 10, 2026
pulisher
Mar 10, 2026

Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT - TMX Newsfile

Mar 10, 2026
pulisher
Mar 10, 2026

Cancer gene-silencing trial shows 65% response in Phio study - Stock Titan

Mar 10, 2026
pulisher
Mar 07, 2026

How Phio Pharmaceuticals Corp. stock compares to industry benchmarksBuy Signal & High Accuracy Trade Signal Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

EV Market: Is Phio Pharmaceuticals Corp being accumulated by smart moneyJuly 2025 Sector Moves & Free Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update - marketscreener.com

Mar 05, 2026
pulisher
Mar 05, 2026

Cancer drug PH-762 completes safety phase as Phio raises $23.7M - Stock Titan

Mar 05, 2026
pulisher
Mar 05, 2026

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - marketscreener.com

Mar 05, 2026
pulisher
Mar 05, 2026

Phio cancer drug PH-762 posts 65% response; CEO hosts live Q&A - Stock Titan

Mar 05, 2026
pulisher
Mar 04, 2026

PHIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients - Sahm

Mar 03, 2026
pulisher
Feb 25, 2026

PHIO Should I Buy - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

PHIO Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 25, 2026
pulisher
Feb 23, 2026

Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company - Weekly Voice

Feb 23, 2026
pulisher
Feb 23, 2026

Phio Pharmaceuticals Reports Promising Phase 1b Results for Skin Cancer Therapy, Plans FDA Submission for 2026 - citybuzz -

Feb 23, 2026
pulisher
Feb 21, 2026

Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894 - The Courier-Journal

Feb 21, 2026
pulisher
Feb 20, 2026

Is Phio Pharmaceuticals Corp. stock trending bullish2025 Major Catalysts & Advanced Technical Analysis Signals - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation - TipRanks

Feb 19, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):